Latest

AMD

Featured Neuroscience Visual Neuroscience

·April 22, 2025·4 min read

Rewiring Retinal Messages to Slow Vision Loss in AMD

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80. New research is uncovering how retinal cells communicate using microRNA and extracellular vesicles (EVs), with the goal of slowing AMD progression.

Featured Neuroscience Visual Neuroscience

·April 17, 2025·6 min read

Gold Nanoparticles Restore Vision in Macular Degeneration

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses. When activated by patterned infrared light, these nanoparticles stimulate retinal cells, bypassing damaged photoreceptors.

Featured Neuroscience Visual Neuroscience

·December 4, 2024·4 min read

Sleep Apnea May Increase Risk of Wet Macular Degeneration

A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD). The research suggests nocturnal hypoxia could affect the oxygen-sensitive retina, contributing to AMD progression.

Featured Genetics Neuroscience Visual Neuroscience

·October 2, 2024·4 min read

Targeting Protein Reduces Macular Degeneration Symptoms

New research identifies a protein, TIMP3, overproduced in age-related macular degeneration (AMD) that may drive the disease’s progression. By targeting the enzyme linked to inflammation and drusen formation, scientists reduced early signs of AMD in stem cell models, offering hope for new treatments.

Featured Genetics Neuroscience Visual Neuroscience

·September 9, 2024·4 min read

Gene Therapy Offers Hope for Glaucoma and AMD

A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss. The therapy protects retinal ganglion cells, essential for vision, and improves their function in animal models of glaucoma. It also enhances energy production in human retinal cells, which could prevent further damage. This therapy offers a new and promising approach to treating a condition that affects millions worldwide.

Featured Neuroscience Visual Neuroscience

·July 16, 2024·6 min read

Antioxidants Slow Vision Loss in Late-Stage Dry AMD

Researchers found that daily antioxidant supplements slow the progression of late-stage dry age-related macular degeneration (AMD). The supplements help preserve central vision by slowing the expansion of geographic atrophy regions in the retina. This finding supports the use of AREDS2 supplements for people with late dry AMD.

Featured Neuroscience Visual Neuroscience

·June 12, 2024·6 min read

Robot System Reduces Eye Injections for AMD Patients

Researchers successfully used a custom-built robot to treat wet age-related macular degeneration (AMD). This minimally invasive treatment reduces the need for frequent eye injections. The landmark study found that robotic radiotherapy significantly decreases the number of injections needed, potentially saving millions annually. The new method offers precise targeting of radiation to the eye, improving patient outcomes and reducing costs.

This shows an older man undergoing an eye exam.

Featured Neuroscience Visual Neuroscience

·June 5, 2024·3 min read

New Breakthrough Treatment for Age-Related Macular Degeneration

Researchers discovered that boosting the protein IRAK-M in retinal cells can effectively treat age-related macular degeneration (AMD). This revolutionary therapy offers a comprehensive approach to AMD, a leading cause of vision loss affecting 200 million people worldwide.

Featured Neuroscience Visual Neuroscience

·October 19, 2023·6 min read

New Eye Clock Predicts Aging Through Fluid Proteins

Researchers have pioneered a method to measure ocular aging by studying proteins in eye fluid. Using artificial intelligence, they crafted an "eye-aging clock" from 26 out of nearly 6,000 proteins which can forecast aging.

Featured Genetics Neuroscience Visual Neuroscience

·August 28, 2023·5 min read

New Cell Atlas Signals Hope for Aging Visual Impairments

Researchers created a groundbreaking "cell atlas" of the human eye that could revolutionize treatments for blinding diseases like glaucoma and macular degeneration. The atlas identifies nearly 160 unique cell types across different eye structures, and pinpoints which genes each cell type expresses.

Featured Genetics Neuroscience Visual Neuroscience

·April 14, 2023·4 min read

Stem Cell Therapy Could Restore Vision to Those With Macular Degeneration and Other Blinding Eye Diseases

A new method enables the production of photoreceptor progenitor cells that resemble embryonic cells. These cells can be transplanted and restore retinal function, and ultimately recovery of vision for those with blinding diseases including age-related macular degeneration and retinitis pigmentosa.

Featured Genetics Neuroscience Visual Neuroscience

·April 1, 2023·3 min read

A Potential Cause of Age-Related Macular Degeneration

Researchers have identified rare genetic variants that may drive age-related macular degeneration. The findings could be key to developing new treatments that could slow the progression of AMD.